Sanofi Joins mRNA COVID-19 Club With Translate Tie-Up
Two-Pronged Approach For A Coronavirus Vaccine
The French drugmaker has joined the likes of Moderna, BioNTech and CureVac in advancing an mRNA vaccine against the virus that causes COVID-19 that could take the fraction of the time to develop compared with the old egg- and cell-based technology.
